• Nachrichtendetail
• 

11.06.2024 13:04:01 - dpa-AFX: *REGENERON AND SANOFI: FDA APPROVES KEVZARA FOR TREATMENT OF ACTIVE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS

	Name	WKN	Börse	Kurs	Datum/Zeit	Diff.	Diff. %	Geld	Brief	Erster	Schluss
	SANOFI SA INHABER EO 2	920657	Xetra	90,170	28.06.24 17:35:54	+0,300	+0,33%	0,000	0,000	90,380	89,870
	Regeneron Pharmaceuticals	881535	NASDAQ	1.051,000	28.06.24 19:55:52	+0,140	+0,01%	1.050,080	1.051,920	1.071,220	1.050,860